CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Alkermes Pharma Ireland Limited v. Intellipharmaceutics Corporation

1:11-cv-00255

Overview

Case Number 1:11-cv-00255
Filing Date 2011-03-28
Status Terminated
Termination Date 2012-09-07
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Intellipharmaceutics Ltd. Operating Company

Represented By

1 Attorneys Listed

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Intellipharmaceutics Corporation NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Par Pharmaceutical Inc. Operating Company

Represented By

1 Attorneys Listed

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Elan Corporation PLC NPE (Individual / Inventor)

Represented By

4 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Richard John Bauer

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9131

1201 North Market Street, P.O. Box 1347

Plaintiff

Alkermes Pharma Ireland Limited NPE (University / Research)

Represented By

4 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Richard John Bauer

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9131

1201 North Market Street, P.O. Box 1347

Elan Pharma International Ltd. Operating Company

Represented By

4 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Richard John Bauer

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9131

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 21 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (21): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6228398
Multiparticulate modified release composition
Filed: 2000-05-08
Issued: 2001-05-08
Expired (Term Ended)
Expires: 2020-05-08
US6730325
Multiparticulate modified release composition
Filed: 2001-05-07
Issued: 2004-05-04
Expired (Term Ended)
Expires: 2021-05-07

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

12

Dispositive

0

Granted

0

Denied

0

Pending / Review

12

Motions by Category

Procedural / Extension Motion 12

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME by which Defendants may respond to the Complaint to August 17, 2012 - filed by Alkermes Pharma Ireland Limited, Intellipharmaceutics ...
Entry #23 • 2012-06-18 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME by which Defendants may respond to the Complaint to June 18, 2012 - filed by Alkermes Pharma Ireland Limited, Intellipharmaceutics Co...
Entry #22 • 2012-05-02 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME by which Defendants Intellipharmaceutics Corporation, Intellipharmaceutics Ltd., and Par Pharmaceutical Inc. shall respond to the Com...
Entry #20 • 2012-03-16 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME by which Defendants shall respond to the Complaint to through and including March 19, 2012 - filed by Alkermes Pharma Ireland Limited...
Entry #19 • 2012-01-30 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME by which Defendants must move, answer, or otherwise respond to the Complaint to February 3, 2012 - filed by Alkermes Pharma Ireland L...
Entry #18 • 2011-12-19 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendants to Respond to the Complaint to December 19, 2011 - filed by Alkermes Pharma Ireland Limited, Intellipharmaceutics Corp...
Entry #17 • 2011-11-15 Document →

Docket Entries

(27 total)
Pleading / Complaint

COMPLAINT filed against Intellipharmaceutics Corporation, Intellipharmaceutics Ltd., and Par Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-866231) - filed by Elan Corporation PLC, Elan Pharma International Ltd.. (Attachments: # 1 Exhibits A - B, # 2 Civil Cover Sheet)(nms) (Entered: 03/28/2011)

Entry #1 • 2011-03-25
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nms) (Entered: 03/28/2011)

Entry #2 • 2011-03-25
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,228,398; 6,730,325. (nms) (Entered: 03/28/2011)

Entry #3 • 2011-03-25
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/10/2011. Date of Expiration of Patent: 11/1/2019.Thirty Month Stay Deadline: 8/11/2013 (see Notice for further details).(nms) (Entered: 03/28/2011)

Entry #4 • 2011-03-25
1

Disclosure Statement pursuant to Rule 7.1 filed by Elan Corporation PLC and Elan Pharma International Ltd.. (nms) (Entered: 03/28/2011)

Entry #5 • 2011-03-25
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc